Eligo Bioscience

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$30M

Eligo Bioscience is a gene-editing biotech company focused on developing precision medicines for immuno-inflammation, oncology, and infectious diseases by leveraging microbiome in-vivo gene editing technologies.